On the origin of calcium oxalate monohydrate papillary renal stones

Urolithiasis

Volumn 43, Issue 1, 2014, Pages 33-39

  Grases, Fèlix ^a   Costa Bauzá, Antonia ^a   Bonarriba, Carlo R ^b   Pieras, Enrique C ^b   Fernández, Rafael A ^a   Rodríguez, Adrián ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Calcium oxalate; Mechanism of formation; Papillary calcifications; Papillary renal calculi

Indexed keywords

ANTIOXIDANT; PHYTATE; WEDDELLITE; WHEWELLITE; CALCIUM OXALATE;

CALCIUM OXALATE STONE; CALCIUM URINE LEVEL; CHRONIC DISEASE; CLINICAL EVALUATION; DIET; DISEASE ASSOCIATION; HUMAN; INJURY SEVERITY; KIDNEY CALCIFICATION; KIDNEY CELL; KIDNEY EPITHELIUM; KIDNEY PAPILLA; MAJOR CLINICAL STUDY; NEPHROLITHIASIS; OCCUPATIONAL EXPOSURE; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; UROLITHIASIS; CALCINOSIS; KIDNEY CALCULI; KIDNEY DISEASES; KIDNEY MEDULLA;

CALCINOSIS; CALCIUM OXALATE; HUMANS; KIDNEY CALCULI; KIDNEY DISEASES; KIDNEY MEDULLA;

EID: 84922076041     PISSN: 21947228     EISSN: 21947236     Source Type: Journal    
DOI: 10.1007/s00240-014-0697-5     Document Type: Review

References (45)

1. Daudon M, Bader CA, Jungers P (1993) Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc 7:1081–1106
2. Grases F, Costa-Bauzá A, Ramis M, Montesinos V, Conte A (2002) Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta 322:29–36
3. Conti C, Brambilla L, Colombo C, Dellasega D, Diego Gatta C, Realini M, Zerbi G (2010) Stability and transformation mechanism of weddellite nanocrystals studied by X-ray diffraction and infrared spectroscopy. Phys Chem Chem Phys 12:14560–14566
4. Randall A (1937) Origin and growth of renal calculi. Ann Surg 105:1009–1027
5. Prien EL (1975) The riddle of Randall’s plaques. J Urol 114:500–507
6. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607–616
7. Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, Munch LC, Evan AP, Lingeman JE (2005) Stone formation is proportional to papillary surface coverage by Randall’s plaque. J Urol 173:117–119
8. O’Connor RC, Worcester EM, Evan AP, Meehan S, Kuznetsov D, Laven B, Sommer AJ, Bledsoe SB, Parks JH, Coe FL, Grynpas M, Gerber GS (2005) Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res 33:105–115
9. Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145–154
10. Grases F, García-Ferragut L, Costa- Bauzá A (1998) Analytical study of renal calculi. A new insight. Recent Res Dev Pure Appl Anal Chem 1:187–206
11. Costa-Bauza A, Grases F, Fakier S, Rodriguez A (2013) A novel metal-dye system for urinary phytate detection at micro-molar levels in rats. Anal Methods 5:3016–3022
12. Conte A, Genestar C, Grases F (1990) Relation between calcium oxalate hydrate form found in renal calculi and some urinary parameters. Urol Int 45:25–27
13. Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MA (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 151:571–574
14. Tsujihata M, Tsujikawa K, Tei N, Yoshimura K, Okuyama A (2006) Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers. Int J Urol 13:197–201
15. Davalos M, Konno S, Eshghi M, Choudhury M (2010) Oxidative renal cell injury induced by calcium oxalate crystal and renoprotection with antioxidants: a possible role of oxidative stress in nephrolithiasis. J Endourol 24:339–345
16. Grases F, March JG, Prieto RM, Simonet BM, Costa-Bauzá A, García-Raja A, Conte A (2000) Urinary phytate in calcium oxalate stone formers and healthy people—dietary effects on phytate excretion. Scand J Urol Nephrol 34:162–164
17. Prieto RM, Fiol M, Perello J, Estruch R, Ros E, Sanchis P, Grases F (2010) Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion. Eur J Nutr 49:321–326
18. McCord JM (1993) Human disease, free radicals and the oxidant/antioxidant balance. J Free Radic Res 26:351–357
19. Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239:70–76
20. Hayes WA, Mills DS, Neville RF, Kiddie J, Collins LM (2011) Determination of the molar extinction coefficient for the ferric reducing/antioxidant power assay. Anal Biochem 416:202–205
21. Khan SR, Rodriguez DE, Gower LB, Monga M (2012) Association of Randall plaque with collagen fibers and membrane vesicles. J Urol 187:1094–1100
22. Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 189:803–811
23. Ouyang JM, Yao XQ, Tan J, Wang FX (2011) Renal epithelial cell injury and its promoting role in formation of calcium oxalate monohydrate. J Biol Inorg Chem 16:405–416
24. Bazin D, Daudon M, Combes C, Rey C (2012) Characterization and some physicochemical aspects of pathological microcalcifications. Chem Rev 112:5092–5120
25. Grases F, Prieto RM, Gomila I, Sanchis P, Costa-Bauzá A (2009) Phytotherapy and renal stones: the role of antioxidants. A pilot study in Wistar rats. Urol Res 37:35–40
26. Khan A, Khan SR, Gilani AH (2012) Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica. Urol Res 40:671–681
27. Chennasamudram SP, Kudugunti S, Boreddy PR, Moridani MY, Vasylyeva TL (2012) Renoprotective effects of (+)-catechin in streptozotocin-induced diabetic rat model. Nutr Res 32:347–356
28. Gandhi M, Aggarwal M, Puri S, Singla SK (2013) Prophylactic effect of coconut water (Cocos nucifera L.) on ethylene glycol induced nephrocalcinosis in male wistar rat. Int Braz J Urol 39:108–117
29. Anderson HC, Morris DC (1993) Mineralization. In: Mundy GR, Martin TJ (eds) Physiology and pharmacology of bone. Springer, New York, pp 267–298
30. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (2002) Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161:2035–2046
31. Romberg RW, Werness PG, Riggs BL, Mann KG (1986) Inhibition of hydroxyapatite crystal growth by bonespecific and other calcium-binding proteins. Biochemistry 25:1176–1180
32. Boskey AL, Maresca M, Ullrich W, Doty SD, Butler WT, Prince CW (1993) Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22:147–159
33. Govindaraj A, Selvam R (2002) An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix. BJU Int 90:336–344
34. Yamate T, Kohri K, Umekawa T et al (1996) The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin–Darby canine kidney cells. Eur Urol 30:388–393
35. Lieske JC, Toback FG, Deganello S (2001) Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int 60:1784–1791
36. Grases F, Isern B, Sanchis P, Perello J, Torres JJ, Costa-Bauza A (2007) Phytate acts as an inhibitor in formation of renal calculi. Front Biosci 12:2580–2587
37. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O’Neill WC (2004) Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 15:1392–1401
38. Wilson JW, Werness PG, Smith LH (1985) Inhibitors of crystal growth of hydroxyapatite: a constant composition approach. J Urol 134:1255–1258
39. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec 290:1315–1323
40. Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL (2010) Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res 38:439–452
41. Takeuchi A, Ohtsuki C, Miyazaki T, Kamitakahara M, Ogata S, Yamazaki M, Furutani Y, Kinoshita H, Tanihara M (2005) Heterogeneous nucleation of hydroxyapatite on protein: structural effect of silk sericin. J R Soc Interface 2:373–378
42. Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059–1063
43. Schwarz A (1993) Beethoven’s renal disease based on his autopsy: a case of papillary necrosis. Am J Kidney Dis 21:643–652
44. Pieras E, Costa-Bauzá A, Ramis M, Grases F (2006) Papillary and nonpapillary calcium oxalate monohydrate renal calculi: comparative study of etiologic factors. Sci World J 6:2411–2419
45. Tarnawski A, Szabo IL, Husain SS, Soreghan B (2001) Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J Physiol Paris 95:337–344